Scenarios that move STVN
Stevanato Group S.p.A. Ordinary Shares
Scenarios that move STVN: 8 analyses, 5 positive, 3 negative.
- · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▲ · impact +27 · confidence low · horizon quarters
- · HALO wins court order blocking Merck's European Keytruda SC — ▼ · impact -16 · confidence low · horizon quarters
- · Zealand Pharma reports positive survodutide Phase III weight loss results — ▲ · impact +44 · confidence low · horizon quarters
- · Novo and Hengrui sign exclusive license for oral GLP-1/GIP drug — ▼ · impact -16 · confidence low · horizon quarters
- · Pharma stock soars 150% after injectables deal with Novo — ▲ · impact +48 · confidence low · horizon quarters
- · ◇ What if… Oral GLP-1 drugs replace injectable treatments — ▼ · impact -73 · confidence medium · horizon quarters
- · Oruka Therapeutics reports positive week 28 ORKA-001 trial data — ▲ · impact +8 · confidence low · horizon quarters
- · Viking Therapeutics stock skyrockets in Tuesday trading — ▲ · impact +34 · confidence low · horizon quarters